Evidence map›Paper›PMID 33301448›Full record

ArticlePloS one2020

In vivo tracking of transplanted macrophages with near infrared fluorescent dye reveals temporal distribution and specific homing in the liver that can be perturbed by clodronate liposomes.

Satoshi Nishiwaki, Shigeki Saito, Kyosuke Takeshita, Hidefumi Kato, Ryuzo Ueda, Akiyoshi Takami, Tomoki Naoe, Mika Ogawa, Takayuki Nakayama

Abstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. In vivo optical molecular imaging of inflammation and immunity.Journal of molecular medicine (Berlin, Germany) · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Satoshi NishiwakiDepartment of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Shigeki SaitoDepartments of Hematology, Japanese Red Cross Nagoya Daiini Hospital, Nagoya, Aichi, Japan.
Kyosuke TakeshitaDepartment of Clinical Laboratory, Saitama Medical Center, Kawagoe, Saitama, Japan.
Hidefumi KatoDepartment of Transfusion Medicine, Aichi Medical University, Nagakute, Aichi, Japan.
Ryuzo UedaTumor Immunology, Aichi Medical University, Nagakute, Aichi, Japan.
Akiyoshi TakamiHematology, Aichi Medical University, Nagakute, Aichi, Japan.
Tomoki NaoeDepartments of Hematology, Nagoya Medical Center, Nagoya, Aichi, Japan.
Mika OgawaClinical Laboratory, Aichi Medical University, Nagakute, Aichi, Japan.
Takayuki NakayamaClinical Laboratory, Aichi Medical University, Nagakute, Aichi, Japan.ORCID 0000-0003-2389-2542

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Macrophages play an indispensable role in both innate and acquired immunity, while the persistence of activated macrophages can sometimes be harmful to the host, resulting in multi-organ damage. Macrophages develop from monocytes in the circulation. However, little is known about the organ affinity of macrophages in the normal state. Using in vivo imaging with XenoLight DiR®, we observed that macrophages showed strong affinity for the liver, spleen and lung, and weak affinity for the gut and bone marrow, but little or no affinity for the kidney and skin. We also found that administered macrophages were still alive 168 hours after injection. On the other hand, treatment with clodronate liposomes, which are readily taken up by macrophages via phagocytosis, strongly reduced the number of macrophages in the liver, spleen and lung.

Indexed as

AnimalsBone MarrowCarbocyaninesCell TrackingClodronic AcidFluorescent DyesIntestinesKidneyLiposomesLiverLungMacrophages, PeritonealMaleMiceMice, Inbred C57BLPhagocytosis1,1'-dioctadecyl-3,3,3',3'-tetramethylindotricarbocyanineCarbocyaninesClodronic AcidFluorescent DyesLiposomes

Identifiers

PMID33301448
PMCPMC7728253

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.